Weyand E H, He Z M, Ghodrati F, Wu Y, Marshall M V, LaVoie E J
Rutgers, State University of New Jersey, College of Pharmacy, Piscataway 08855-0789.
Chem Biol Interact. 1992 Sep 14;84(1):37-53. doi: 10.1016/0009-2797(92)90119-6.
The metabolism and mutagenic activity of 4-fluorobenzo[j]fluoranthene (4F-B[j]F) and 10-fluorobenzo[j]fluoranthene (10F-B[j]F) were evaluated and compared with benzo[j]fluoranthene (B[j]F) using an identical rat liver homogenate preparation. Previous studies have shown that the major genotoxic metabolites of B[j]F are the 4,5- and 9,10-dihydrodiol. The 9,10-dihydrodiol was the principal metabolite formed in the case of 4F-B[j]F, while the 4,5-dihydrodiol was the principal metabolite formed in the metabolism of 10F-B[j]F. Studies on the relative genotoxicity of these fluorinated derivatives were performed to indirectly determine the possible contribution of the 4,5- and 9,10-dihydrodiol in the activation of B[j]F to a genotoxic agent. In the presence of microsomal activation, both of these fluorinated derivatives of B[j]F were more mutagenic in S. typhimurium TA97a, TA98 and TA100 than B[j]F. However, differences in mutagenic potency were observed between 4F- and 10F-B[j]F. 10F-B[j]F had similar mutagenic potency to 4F-B[j]F in TA97a and TA98 at doses associated with the linear portion of the dose response curve. However, a slightly higher mutagenic response was observed with 10F-B[j]F in TA98 at doses above 5 nmol. In contrast, 4F-B[j]F was more active than 10F-B[j]F as a mutagen in TA100. The tumor-initiating activity of these analogs on mouse skin was assessed at doses of 2.0, 1.0 and 0.3 mumol. Skin irritation was observed with the fluorinated B[j]F derivatives at doses above 0.3 mumol. At a dose of 0.3 mumol, 4F-B[j]F exhibited tumorigenic activity which was similar to B[j]F. In contrast, 10F-B[j]F was less active than B[j]F at all three doses assayed. Both fluorinated derivatives of B[j]F formed higher levels of DNA adducts in vivo in mouse skin than B[j]F. A modified 32P-postlabeling method was required to detect fast migrating B[j]F:DNA adducts that went undetected in previous studies. The level of DNA adducts formed from 4F-B[j]F was considerably greater than the levels observed with 10F-B[j]F. This is consistent with the greater mutagenic activity in S. typhimurium TA100 and tumor-initiating activity exhibited by 4F-B[j]F. These studies suggest that fluorine substitution may significantly alter the intrinsic genotoxicity of the 4,5- and 9,10-dihydrodiol of B[j]F. These data also imply that B[j]F may be primarily activated via the formation of the 9,10-dihydrodiol metabolite. This pathway of activation is inconsistent with our previous studies which indicate that the 4,5-dihydrodiol is the most important pathway of activation.(ABSTRACT TRUNCATED AT 400 WORDS)
使用相同的大鼠肝脏匀浆制剂,对4-氟苯并[j]荧蒽(4F-B[j]F)和10-氟苯并[j]荧蒽(10F-B[j]F)的代谢和诱变活性进行了评估,并与苯并[j]荧蒽(B[j]F)进行了比较。先前的研究表明,B[j]F的主要遗传毒性代谢物是4,5-二氢二醇和9,10-二氢二醇。9,10-二氢二醇是4F-B[j]F形成的主要代谢物,而4,5-二氢二醇是10F-B[j]F代谢过程中形成的主要代谢物。对这些氟化衍生物的相对遗传毒性进行了研究,以间接确定4,5-二氢二醇和9,10-二氢二醇在将B[j]F活化为遗传毒性剂过程中可能的作用。在微粒体激活存在的情况下,B[j]F的这两种氟化衍生物在鼠伤寒沙门氏菌TA97a、TA98和TA100中比B[j]F更具诱变性。然而,观察到4F-B[j]F和10F-B[j]F之间诱变效力存在差异。在与剂量反应曲线线性部分相关的剂量下,10F-B[j]F在TA97a和TA98中的诱变效力与4F-B[j]F相似。然而,在高于5 nmol的剂量下,在TA98中观察到10F-B[j]F的诱变反应略高。相比之下,4F-B[j]F在TA100中作为诱变剂比10F-B[j]F更具活性。在2.0、1.0和0.3 μmol的剂量下评估了这些类似物对小鼠皮肤的肿瘤启动活性。在高于0.3 μmol的剂量下,观察到氟化B[j]F衍生物有皮肤刺激。在0.3 μmol的剂量下,4F-B[j]F表现出与B[j]F相似的致瘤活性。相比之下,在所有三种测定剂量下,10F-B[j]F的活性均低于B[j]F。B[j]F的两种氟化衍生物在小鼠皮肤体内形成的DNA加合物水平均高于B[j]F。需要一种改进的32P后标记方法来检测先前研究中未检测到的快速迁移的B[j]F:DNA加合物。4F-B[j]F形成的DNA加合物水平明显高于10F-B[j]F观察到的水平。这与4F-B[j]F在鼠伤寒沙门氏菌TA100中更大的诱变活性和肿瘤启动活性一致。这些研究表明,氟取代可能会显著改变B[j]F的4,5-二氢二醇和9,10-二氢二醇的内在遗传毒性。这些数据还表明,B[j]F可能主要通过9,10-二氢二醇代谢物的形成而被激活。这种激活途径与我们先前的研究不一致,我们先前的研究表明4,5-二氢二醇是最重要的激活途径。(摘要截断于400字)